Works in Patient Care (Online), 2025
Results: 318
Daniel Butler, MD: Pearls for Primary Care When Treating and Referring Older Adults for Chronic Itch.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Zabalafin Hydrogel Shows Efficacy in Atopic Dermatitis, Including Cases with Bacterial Infection.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Delgocitinib Data Reveal "Super Responders" in CHE During AAD 2025 Late Breaker.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Atopic Dermatitis: It's Not the Food, I Promise You.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
FDA Approves Omlyclo as First Interchangeable Omalizumab Biosimilar.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Elizabeth Swanson, MD: When HSV Causes Big Dermatological Problems.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
For Atopic Dermatitis, "The Treatment Drought is Over," Says Expert Dermatologist Emma Guttman, MD, PhD.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Brian S. Kim, MD: Why Primary Care Clinicians Should Prescribe New Treatments for Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
The Complexities of Treating Rosacea, with Benjamin Ungar, MD.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
The Link Between Itch and Aging, with Daniel Butler, MD.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Dupilumab Demonstrates Superior Long-Term Persistence Over Upadacitinib and Tralokinumab in Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Rocatinlimab, an OX40 Inhibitor, Achieves Positive Results in Atopic Dermatitis Treatment: ROCKET-Horizon Topline Findings.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Atopic Dermatitis Breakthrough: Linda Stein Gold, MD, on Tapinarof's Treatment-Free Benefits.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Benjmain Ungar, MD: Addressing the Immunological Causes of Seborrheic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Daniel Butler, MD: Pearls for Primary Care When Treating and Referring Older Adults for Chronic Itch.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
AAD 2025: Clear Skin in Half of Patients Who Received Monthly Maintenance Injection of Ebglyss for AD.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Atopic Dermatitis: Investigational Anti-OX40L Antibody Shows Sustained Itch Relief, Even After Discontinuation.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Roflumilast Cream 0.15% Well Tolerated in Atopic Dermatitis Patients with Prior Treatment Failures.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Atopic Dermatitis: It's Not the Food, I Promise You.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Roflumilast Cream 0.15% Well Tolerated in Atopic Dermatitis Patients with Prior Treatment Failures.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp and Body Psoriasis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Bimekizumab Demonstrates Sustained Efficacy in Moderate-to-Severe Plaque Psoriasis Over Five Years.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
AAD 2025: Clear Skin in Half of Patients Who Received Monthly Maintenance Injection of Ebglyss for AD.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Real-World Evidence Reveals Key Insights on Hidradenitis Suppurativa.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Tildrakizumab Shows Efficacy for Nail Psoriasis in Phase 3b Trial.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
AAD 2025: Atopic Dermatitis Preview.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
FDA Approves Neffy 1 mg Epinephrine Nasal Spray, Only Needle-Free Treatment for Patients Weighing Less Than 30 kg.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
Dupilumab Shows Efficacy and Safety in COPD With Type 2 Inflammation: AAAAI 2025.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
FDA Accepts Depemokimab BLA for Asthma and Chronic Rhinosinusitis with Nasal Polyps.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article
New Nonsteroidal Topical Treatment Options for Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Diagnosing and Defining Severity of Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Addressing Itch and Quality of Life for Patients With Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Depemokimab Shows Significant Improvements in Rhinosinusitis with Nasal Polyps: New Research.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Colonoscopy Bowel Prep Guidelines Updated by US Multi-Society Task Force on Colorectal Cancer.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Study Reveals Persistent Telehealth Disparities in Depression Management: Daily Dose.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Older Approaches to Topical Treatment of Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Long-Term Use of Topical Treatments in Atopic Dermatitis.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Investigational Ketogenic Diet Pill BL-001 Shows Significant Weight Loss in Phase 1 Trial.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
First Rivaroxaban Generics (2.5 mg) Get FDA Approval.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
Shifting Trends in Severe Asthma Biologics: Daily Dose.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- By:
- Publication type:
- Article
FDA VRBAC Meeting Cancelled, Fueling Concerns for Delays in 2025 Season Production.
- Published in:
- Patient Care (Online), 2025, p. N.PAG
- Publication type:
- Article